{"entity":"johnson-johnson","id":"ent_johnson-johnson","name":"Johnson & Johnson","from":"2025-11-08","to":"2026-11-08","page":"https://asof.is/record/johnson-johnson/diff?from=2025-11-08&to=2026-11-08","summary":"Between 2025-11-08 and 2026-11-08, Johnson & Johnson's record changed in 15 facts: 3 replaced (net income $14.07 billion → $26.8 billion; research and development $1.84 billion → $109 million; revenue $88.82 billion → $94.19 billion), 6 added, 6 ended; 12 unchanged.","counts":{"changed":15,"added":6,"ended":6,"replaced":3,"unchanged":12,"skipped_posts":{"from":0,"to":0}},"by_predicate":[{"predicate":"cash_and_equivalents","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_net_income","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_revenue","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"shares_outstanding","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_assets","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_equity","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"net_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"research_and_development","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"revenue","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"cik","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"fiscal_year_end","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"headquarters","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"listed_on","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"operating_income","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"quarterly_operating_income","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"registrant_name","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"sic_industry","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"state_of_incorporation","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"ticker","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"website","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"x_username","added":0,"ended":0,"replaced":0,"unchanged":1}],"added":[{"id":"clm_B2E80FDC373C","predicate":"cash_and_equivalents","value":"16,910,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 16,910,000,000 United States dollar\", as of 2026-09-27. Claim clm_B2E80FDC373C, https://asof.is/claim/clm_B2E80FDC373C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_B2E80FDC373C","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_DE9082D90894","predicate":"quarterly_net_income","value":"210,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 210,000,000 United States dollar\", as of 2026-09-27. Claim clm_DE9082D90894, https://asof.is/claim/clm_DE9082D90894, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_DE9082D90894","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_0641FC210206","predicate":"quarterly_revenue","value":"25,399,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 25,399,000,000 United States dollar\", as of 2026-09-27. Claim clm_0641FC210206, https://asof.is/claim/clm_0641FC210206, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_0641FC210206","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_7504E6D195B0","predicate":"shares_outstanding","value":"2,407,310,266 shares","valid_from":"2026-10-15","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,407,310,266 shares\", as of 2026-10-15. Claim clm_7504E6D195B0, https://asof.is/claim/clm_7504E6D195B0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_7504E6D195B0","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_0B98C34873D9","predicate":"total_assets","value":"197,425,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 197,425,000,000 United States dollar\", as of 2026-09-27. Claim clm_0B98C34873D9, https://asof.is/claim/clm_0B98C34873D9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_0B98C34873D9","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_F6CBCD569325","predicate":"total_equity","value":"81,529,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 81,529,000,000 United States dollar\", as of 2026-09-27. Claim clm_F6CBCD569325, https://asof.is/claim/clm_F6CBCD569325, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_F6CBCD569325","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-10-21"}}],"ended":[{"id":"clm_A4F230EF9BBB","predicate":"cash_and_equivalents","value":"18,231,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,231,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_A4F230EF9BBB, https://asof.is/claim/clm_A4F230EF9BBB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_A4F230EF9BBB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9D46DE0A4F23","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_4AB4EF856D4C","predicate":"quarterly_net_income","value":"5,152,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2026-03-29","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,152,000,000 United States dollar\", as of 2025-09-28 (until 2026-03-29). Claim clm_4AB4EF856D4C, https://asof.is/claim/clm_4AB4EF856D4C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_4AB4EF856D4C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_636E850C3608","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_729D980FE153","predicate":"quarterly_revenue","value":"23,993,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2026-03-29","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 23,993,000,000 United States dollar\", as of 2025-09-28 (until 2026-03-29). Claim clm_729D980FE153, https://asof.is/claim/clm_729D980FE153, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_729D980FE153","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1D62C3B5C845","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_D97FEC131483","predicate":"shares_outstanding","value":"2,409,295,102 shares","valid_from":"2025-10-17","valid_to":"2026-02-06","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,409,295,102 shares\", as of 2025-10-17 (until 2026-02-06). Claim clm_D97FEC131483, https://asof.is/claim/clm_D97FEC131483, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_D97FEC131483","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD98E84FA8C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_7E3589121DB9","predicate":"total_assets","value":"192,816,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 192,816,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_7E3589121DB9, https://asof.is/claim/clm_7E3589121DB9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_7E3589121DB9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AFEC68E6D52E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_63969A827BEB","predicate":"total_equity","value":"79,277,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 79,277,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_63969A827BEB, https://asof.is/claim/clm_63969A827BEB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_63969A827BEB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BDE73F201969","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-22"}}],"replaced":[{"predicate":"net_income","from":{"id":"clm_62CFC14840C5","predicate":"net_income","value":"14,066,000,000 United States dollar","valid_from":"2024-12-29","valid_to":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 14,066,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_62CFC14840C5, https://asof.is/claim/clm_62CFC14840C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_62CFC14840C5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_04E6B87CA267","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-13T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-13"}},"to":{"id":"clm_04E6B87CA267","predicate":"net_income","value":"26,804,000,000 United States dollar","valid_from":"2025-12-28","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 26,804,000,000 United States dollar\", as of 2025-12-28. Claim clm_04E6B87CA267, https://asof.is/claim/clm_04E6B87CA267, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_04E6B87CA267","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-11"}}},{"predicate":"research_and_development","from":{"id":"clm_447FFAF7D0DA","predicate":"research_and_development","value":"1,841,000,000 United States dollar","valid_from":"2024-12-29","valid_to":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 1,841,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_447FFAF7D0DA, https://asof.is/claim/clm_447FFAF7D0DA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_447FFAF7D0DA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_845673D0E6C8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-13T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-13"}},"to":{"id":"clm_845673D0E6C8","predicate":"research_and_development","value":"109,000,000 United States dollar","valid_from":"2025-12-28","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 109,000,000 United States dollar\", as of 2025-12-28. Claim clm_845673D0E6C8, https://asof.is/claim/clm_845673D0E6C8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_845673D0E6C8","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-11"}}},{"predicate":"revenue","from":{"id":"clm_948A7BE90437","predicate":"revenue","value":"88,821,000,000 United States dollar","valid_from":"2024-12-29","valid_to":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 88,821,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_948A7BE90437, https://asof.is/claim/clm_948A7BE90437, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_948A7BE90437","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_249E6427F083","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-13T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2024, filed 2025-02-13"}},"to":{"id":"clm_249E6427F083","predicate":"revenue","value":"94,193,000,000 United States dollar","valid_from":"2025-12-28","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 94,193,000,000 United States dollar\", as of 2025-12-28. Claim clm_249E6427F083, https://asof.is/claim/clm_249E6427F083, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_249E6427F083","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2025, filed 2026-02-11"}}}],"rule":"Two states compared by claim id: in both, unchanged; only on to, added; only on from, ended. An ended and an added claim on one predicate are a replacement when the ended one points to the added (superseded_by), or the predicate has exactly one of each and the added begins the day the ended ends. Added rows are labelled for to, ended rows for from. Posts and Hugging Face repos are counted in skipped_posts, not listed.","legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}